Abstract:Infantile hemangioma is one of the most common tumors in infancy. Delivery may be a clue for the trigger of infantile hemangioma formation in the head and face areas. In this study, we tried to plot localization of infantile hemangioma as well as capillary malformation on the head and face, and compared them to identify their characteristics and risk factors. The distribution of 104 lesions in 100 patients with infantile hemangioma was as follows: 32 lesions on the head, 12 on the forehead, 57 on the cheek and… Show more
“…This tendency was not found in 40 patients with capillary malformation. Mechanical stress to the jaw or chin areas may be lesser than in other areas in normal cephalic delivery, so these data may indicate the contribution of mechanical stress as a trigger of infantile hemangioma, not capillary malformation [35].…”
Vascular anomalies include various diseases, which are classified into two types according to the International Society for the Study of Vascular Anomalies (ISSVA) classification: vascular tumors with proliferative changes of endothelial cells, and vascular malformations primarily consisting of structural vascular abnormalities. The most recent ISSVA classifications, published in 2018, detail the causative genes involved in many lesions. Here, we summarize the latest findings on genetic abnormalities, with the presentation of the molecular pathology of vascular anomalies.
“…This tendency was not found in 40 patients with capillary malformation. Mechanical stress to the jaw or chin areas may be lesser than in other areas in normal cephalic delivery, so these data may indicate the contribution of mechanical stress as a trigger of infantile hemangioma, not capillary malformation [35].…”
Vascular anomalies include various diseases, which are classified into two types according to the International Society for the Study of Vascular Anomalies (ISSVA) classification: vascular tumors with proliferative changes of endothelial cells, and vascular malformations primarily consisting of structural vascular abnormalities. The most recent ISSVA classifications, published in 2018, detail the causative genes involved in many lesions. Here, we summarize the latest findings on genetic abnormalities, with the presentation of the molecular pathology of vascular anomalies.
“…The highest number of cases of proliferating and involuting hemangiomas were excised from the head and neck region, and the involuted hemangioma is located predominantly on the trunk. Arterio-venous malformations were most frequently excised from the limbs, having the same location as the data in the literature [21].…”
Infantile and congenital hemangiomas still a challenge for both the pediatric surgeon and the pediatrician. The treatment of hemangiomas must be individualized according to: the type of lesion, location, size, depth, stage of growth and evolution of the lesion. To date, none of the available therapies is considered standard therapy. Currently, personalized therapy is not widely applied in Romania, not being included in the usual therapy protocols in any of the types of hemangioma. This is a starting point for the identification of new specific therapeutic targets that preserve normal endothelial cells and determine the regression of hemangioma, especially recurrent ones and those with an increased proliferation rate. Another controversial and unexplained aspect, consequently unexploited from a therapeutic point of view is represented by the expression and role of lymphatic markers in infantile and congenital hemangiomas.
“…Similar structures also occurred in CH and PG. In CH, there were obvious and irregular lobulated structures with brous tissue separation and central drainage vessels [1,6,13,14] (Figure 3 C); In PG, such structures easily protruded to the epidermis, and were surrounded by squamous epithelium on both sides, showing a "collar" like change [15][16][17] (Figure 3 D). In IH, ECs clusters were characterized by dense proliferation of ECs (Figure 3 G).…”
Background: Infantile hemangioma (IH) is the most common benign tumor in children with the characteristics of endothelial cells (ECs) proliferation and natural regression, and recent evidence shows that abnormal proliferation of ECs of IH is closely related to Apelin and Apelin receptor (APLN/APJ). This study aimed to evaluate and compare the immunoexpression of APLN/APJ and angiogenic index about IH, and establish the specificity with the histomorphology.
Methods: 3 IHs(proliferating), 3 IHs(involuting), 3 congenital hemangiomas (CHs), 3 pyogenic granulomas (PGs), 3 capillary malformations (CMs), and 3 venous malformations (VMs) were submitted to morphological and immunohistochemical analysis. APLN/APJ expression was semi-quantitatively evaluated, and the angiogenic index was assessed by microvessel counts (MVC).
Results: Higher APLN/APJ immunoexpression was observed in the proliferating phase of IHs compared to the involuting phase of IHs (p < 0.05). Compared with CD31, APJ/APLN only expressed in proliferating and partial involuting phases of IHs; Compared with GLUT-1, APLN/APJ was expressed specifically in IH vascular ECs. APLN/APJ expression and angiogenic index significantly correlated in the IHs study.
Conclusions: our research suggests that the expression of APLN/APJ in IH is specific, and may reflect the influence on the initiation and regulation of IH, which can be used as a new specific antibody for clinical pathological diagnosis and a new target for clinical treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.